Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03911687 · ClinicalTrials.gov registry record · NA
(CONCERN) Clinical Decision Support (CDS) System
A NA study of Hospital Acquired Condition, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 60,893
- Enrollment target
- 4
- Study locations
NCT03911687: Completed NA study of Hospital Acquired Condition, sponsored by Columbia University.
NCT03911687 is a NA study of Hospital Acquired Condition that has completed, run by Columbia University. The registered enrollment target is 60,893 participants, above the 765-participant average among 5 other Hospital Acquired Condition trials with a reported enrollment target (7860% higher). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03911687, a NA study of Hospital Acquired Condition, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60,893 participants
- Enrollment target
- 4
- Study locations
Study Summary
There are patients who die or have a bad outcome in the hospital and this could be prevented. Data in the nurses' notes could be used by computers to tell the rest of the care team that a patient is not doing well and that they should act more quickly. This project will build and evaluate a computer system that makes it easier for the care team to see and understand that data and act quickly to save patients. The aims of this study is to answer the questions, what is the level of provider use of the CONCERN CDS notification system (called CONCERN SMARTapp) and resulting impact on selected patient outcomes? Specifically, the study has 1) validated desired thresholds for the CONCERN CDS system and 2) integrated the CONCERN CDS system for early warning of risky patient states within CDS tools. In this portion of the study (aim 3), the investigator will implement and evaluate the CONCERN CDS system on primary outcomes of in-hospital mortality and length of stay and secondary outcomes of cardiac arrest, unanticipated transfers to the intensive care unit, and 30-day hospital readmission rates.
Primary Outcome
Number of patient deaths occurring in the hospital.
Conditions Studied
Interventions
- BEHAVIORAL CONCERN CDS system notification
Study Locations (4)
Massachusetts
- Brigham and Women's Hospital - Boston
- Newton-Wellesley Hospital - Newton
New York
- New York Presbyterian Columbia University Medical Center - New York
- New York Presbyterian Allen Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60,893 participants |
| Start Date | 2020-07-21 |
| Est. Completion | 2022-10-31 |
| Phase | NA |
What the finished NCT03911687 record still lists
NCT03911687 is an interventional study that assigns participants to a tested intervention. Its 60,893 participants enrollment target places it among the larger protocols in the corpus, above the 765-participant average among 5 other Hospital Acquired Condition trials with a reported enrollment target (7860% higher).
The record links to 1 condition, with Hospital Acquired Condition appearing as the primary indexed condition, and to 1 intervention - of which CONCERN CDS system notification is the first listed.
NCT03911687 reports a single indexed study location in Massachusetts, New York.
Frequently Asked Questions
What is clinical trial NCT03911687 about?
NCT03911687 is a clinical study titled "(CONCERN) Clinical Decision Support (CDS) System". There are patients who die or have a bad outcome in the hospital and this could be prevented. Data in the nurses' notes could be used by computers to tell the rest of the care team that a patient is not doing well and that they should act more quickly. This project will build and evaluate a computer...
What is the current status of trial NCT03911687?
This trial is currently completed. It is a NA study. The enrollment target is 60,893 participants. The study started on 2020-07-21. Estimated completion is 2022-10-31.
What conditions does trial NCT03911687 study?
This clinical trial studies the following conditions: Hospital Acquired Condition.
What interventions are being tested in trial NCT03911687?
The interventions under investigation include: CONCERN CDS system notification (BEHAVIORAL).
Who is sponsoring clinical trial NCT03911687?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03911687 being conducted?
This trial has 4 study locations across Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hospital Acquired Condition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
YOOMI: Effect of Gamified Physical Therapy Exercise Software on Inpatient Mobility
RECRUITING · NA
-
Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients
RECRUITING · NA
-
Choosing Wisely: De-implementing Fall Prevention Alarms in Hospitals
RECRUITING · NA
-
Improving Patient Walking During Hospitalization
ACTIVE NOT RECRUITING · NA
-
Delirium Identification in Older Patients With Alzheimer's and Other Related Dementias In the Emergency Department
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03752840 · 60,200 participants · NA
Village-Integrated Eye Worker Trial II
- NCT05723614 · 61,770 participants · NA
TRUsted rEsidents and Housing Assistance to Decrease Violence Exposure in New Haven
- NCT00785525 · 60,000 participants · Phase 3
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
- NCT01825499 · 60,000 participants
Vermont Oxford Network Very Low Birth Weight Database
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI